Important safety information
Prescription treatment requires an individual clinical assessment. This page is general information, not a substitute for your clinician's advice or pharmacy instructions.
Compounded medications are not FDA-approved. FDA does not review them for safety, effectiveness, or quality. A compounded treatment must meet applicable legal conditions and a patient's individual medical need. It is not automatically appropriate because a patient prefers a lower price or a particular ingredient combination.
Semaglutide/B12 program
This program refers to a compounded semaglutide-based treatment option with vitamin B12. Availability of a particular formulation must be confirmed by the clinician and dispensing pharmacy. Listing the program does not establish that this combination is suitable for you or that adding B12 improves treatment outcomes.
Tirzepatide/B12 program
This program refers to a compounded tirzepatide-based treatment option with vitamin B12. Availability of a particular formulation must be confirmed by the clinician and dispensing pharmacy. Your clinician decides whether treatment is appropriate and establishes any prescribed dose and follow-up plan.
Discuss your full health history
Tell your clinician about your medical conditions, allergies, all medications and supplements, pregnancy or pregnancy plans, and breastfeeding. Review contraindications, interactions, potential side effects, and the full instructions supplied for any prescribed medication. This page is not a complete list of warnings.
Dosing and handling
Compounded products can vary in concentration and dosing instructions. Do not calculate a dose from an online chart or from another patient's prescription. Ask the dispensing pharmacist to confirm your dose, measuring device, and instructions if anything is unclear. Follow the pharmacy's storage and delivery guidance.
Report a problem
For questions about a prescription or adverse effects, contact your treating clinician and dispensing pharmacy. Seek urgent in-person care for severe symptoms. Call 911 for an emergency.
Read FDA's information about unapproved GLP-1 drugs and FDA's warning about dosing errors with compounded semaglutide.